Skip to main content
Advertisement
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates


Improved Turnaround Times | Median time to first decision: 12 days

Research ArticleFunctional

MR Spectroscopy Findings in Early Stages of Motor Neuron Disease

M.M. van der Graaff, C. Lavini, E.M. Akkerman, Ch.B. Majoie, A.J. Nederveen, A.H. Zwinderman, F. Brugman, L.H. van den Berg, J.M.B.V. de Jong and M. de Visser
American Journal of Neuroradiology November 2010, 31 (10) 1799-1806; DOI: https://doi.org/10.3174/ajnr.A2217
M.M. van der Graaff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Lavini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.M. Akkerman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ch.B. Majoie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.J. Nederveen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.H. Zwinderman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Brugman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L.H. van den Berg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.M.B.V. de Jong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. de Visser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Czaplinski A,
    2. Yen AA,
    3. Simpson EP,
    4. et al
    . Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 2006;34:702–08
    CrossRefPubMedWeb of ScienceGoogle Scholar
  2. 2.↵
    1. Zoccolella S,
    2. Beghi E,
    3. Palagano G,
    4. et al
    . Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2008;79:33–37
    Abstract/FREE Full TextGoogle Scholar
  3. 3.↵
    1. Chou SM,
    2. Norris FH
    . Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve 1993;16:864–69
    CrossRefPubMedWeb of ScienceGoogle Scholar
  4. 4.↵
    1. Eisen A
    . Motor neuron disease: a primary disorder of corticomotoneurons? Muscle Nerve 1995;18:1080–81
    PubMedWeb of ScienceGoogle Scholar
  5. 5.↵
    1. Pamphlett R,
    2. Kril J,
    3. Hng TM
    . Motor neuron disease: a primary disorder of corticomotoneurons? Muscle Nerve 1995;18:314–18
    CrossRefPubMedWeb of ScienceGoogle Scholar
  6. 6.↵
    1. Visser J,
    2. van den Berg-Vos RM,
    3. Franssen H,
    4. et al
    . Mimic syndromes in sporadic cases of progressive spinal muscular atrophy. Neurology 2002;58:1593–96
    Abstract/FREE Full TextGoogle Scholar
  7. 7.↵
    1. Ince PG,
    2. Evans J,
    3. Knopp M,
    4. et al
    . Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003;60:1252–58
    Abstract/FREE Full TextGoogle Scholar
  8. 8.↵
    1. Kim WK,
    2. Liu X,
    3. Sandner J,
    4. et al
    . Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009;73:1686–92
    Abstract/FREE Full TextGoogle Scholar
  9. 9.↵
    1. Visser J,
    2. van den Berg-Vos RM,
    3. Franssen H,
    4. et al
    . Disease course and prognostic factors of progressive muscular atrophy. Arch Neurol 2007;64:522–28
    CrossRefPubMedWeb of ScienceGoogle Scholar
  10. 10.↵
    1. Gordon PH,
    2. Cheng B,
    3. Katz IB,
    4. et al
    . The natural history of primary lateral sclerosis. Neurology 2006;66:647–53
    Abstract/FREE Full TextGoogle Scholar
  11. 11.↵
    1. Pringle CE,
    2. Hudson AJ,
    3. Munoz DG,
    4. et al
    . Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain 1992;115(pt 2):495–520
    Abstract/FREE Full TextGoogle Scholar
  12. 12.↵
    1. Demougeot C,
    2. Garnier P,
    3. Mossiat C,
    4. et al
    . N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 2001;77:408–15
    CrossRefPubMedWeb of ScienceGoogle Scholar
  13. 13.↵
    1. Pioro EP,
    2. Antel JP,
    3. Cashman NR,
    4. et al
    . Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44:1933–38
    Abstract/FREE Full TextGoogle Scholar
  14. 14.↵
    1. Block W,
    2. Karitzky J,
    3. Traber F,
    4. et al
    . Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 1998;55:931–36
    CrossRefPubMedWeb of ScienceGoogle Scholar
  15. 15.↵
    1. Chan S,
    2. Shungu DC,
    3. Douglas-Akinwande A,
    4. et al
    . Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999;212:763–69
    PubMedWeb of ScienceGoogle Scholar
  16. 16.↵
    1. Gredal O,
    2. Rosenbaum S,
    3. Topp S,
    4. et al
    . Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997;48:878–81
    Abstract/FREE Full TextGoogle Scholar
  17. 17.↵
    1. Pohl C,
    2. Block W,
    3. Karitzky J,
    4. et al
    . Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001;58:729–35
    CrossRefPubMedWeb of ScienceGoogle Scholar
  18. 18.↵
    1. Brand A,
    2. Richter-Landsberg C,
    3. Leibfritz D
    . Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289–98
    CrossRefPubMedWeb of ScienceGoogle Scholar
  19. 19.↵
    1. Kalra S,
    2. Hanstock CC,
    3. Martin WR,
    4. et al
    . Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch Neurol 2006;63:1144–48
    CrossRefPubMedGoogle Scholar
  20. 20.↵
    1. De Stefano N,
    2. Filippi M,
    3. Miller D,
    4. et al
    . Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology 2007;69:1942–52
    Abstract/FREE Full TextGoogle Scholar
  21. 21.↵
    1. Pioro EP,
    2. Majors AW,
    3. Mitsumoto H,
    4. et al
    . 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 1999;53:71–79
    Abstract/FREE Full TextGoogle Scholar
  22. 22.↵
    1. Brooks BR,
    2. Miller RG,
    3. Swash M,
    4. et al
    . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–99
    CrossRefPubMedWeb of ScienceGoogle Scholar
  23. 23.↵
    1. Brugman F,
    2. Wokke JH,
    3. Scheffer H,
    4. et al
    . Spastin mutations in sporadic adult-onset upper motor neuron syndromes. Ann Neurol 2005;58:865–69
    CrossRefPubMedWeb of ScienceGoogle Scholar
  24. 24.↵
    1. Brugman F,
    2. Scheffer H,
    3. Wokke JH,
    4. et al
    . Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology 2008;71:1500–05
    Abstract/FREE Full TextGoogle Scholar
  25. 25.↵
    1. Kent-Braun JA,
    2. Walker CH,
    3. Weiner MW,
    4. et al
    . Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve 1998;21:762–68
    CrossRefPubMedWeb of ScienceGoogle Scholar
  26. 26.↵
    1. Cedarbaum JM,
    2. Stambler N,
    3. Malta E,
    4. et al
    . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function—BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13–21
    CrossRefPubMedWeb of ScienceGoogle Scholar
  27. 27.↵
    1. Ellis CM,
    2. Simmons A,
    3. Jones DK,
    4. et al
    . Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999;53:1051–58
    Abstract/FREE Full TextGoogle Scholar
  28. 28.↵
    1. Naidich TP,
    2. Grant JL,
    3. Altman N,
    4. et al
    . The developing cerebral surface: preliminary report on the patterns of sulcal and gyral maturation—anatomy, ultrasound, and magnetic resonance imaging. Neuroimaging Clin N Am 1994;4:201–40
    PubMedGoogle Scholar
  29. 29.↵
    1. Provencher SW
    . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79
    CrossRefPubMedWeb of ScienceGoogle Scholar
  30. 30.↵
    1. Sarchielli P,
    2. Pelliccioli GP,
    3. Tarducci R,
    4. et al
    . Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001;43:189–97
    CrossRefPubMedWeb of ScienceGoogle Scholar
  31. 31.↵
    1. Czaplinski A,
    2. Yen AA,
    3. Appel SH
    . Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 2006;253:1428–36
    CrossRefPubMedWeb of ScienceGoogle Scholar
  32. 32.↵
    1. Cima V,
    2. Logroscino G,
    3. D'Ascenzo C,
    4. et al
    . Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur J Neurol 2009;16:920–24. Epub 2009 Mar 31
    CrossRefPubMedGoogle Scholar
  33. 33.↵
    1. Czaplinski A,
    2. Yen AA,
    3. Simpson EP,
    4. et al
    . Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? Arch Neurol 2006;63:1139–43
    CrossRefPubMedWeb of ScienceGoogle Scholar
  34. 34.↵
    1. Zhai P,
    2. Pagan F,
    3. Statland J,
    4. et al
    . Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes? Neurology 2003;60:1258–65
    Abstract/FREE Full TextGoogle Scholar
  35. 35.↵
    1. Boillee S,
    2. Yamanaka K,
    3. Lobsiger CS,
    4. et al
    . Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006;312:1389–92
    Abstract/FREE Full TextGoogle Scholar
  36. 36.↵
    1. Cwik VA,
    2. Hanstock CC,
    3. Allen PS,
    4. et al
    . Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998;50:72–77
    Abstract/FREE Full TextGoogle Scholar
  37. 37.↵
    1. Ellis CM,
    2. Simmons A,
    3. Andrews C,
    4. et al
    . A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998;51:1104–09
    Abstract/FREE Full TextGoogle Scholar
  38. 38.↵
    1. Kaufmann P,
    2. Pullman SL,
    3. Shungu DC,
    4. et al
    . Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004;62:1753–57
    Abstract/FREE Full TextGoogle Scholar
  39. 39.↵
    1. Mitsumoto H,
    2. Ulug AM,
    3. Pullman SL,
    4. et al
    . Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007;68:1402–10
    Abstract/FREE Full TextGoogle Scholar
  40. 40.↵
    1. Rule RR,
    2. Schuff N,
    3. Miller RG,
    4. et al
    . Gray matter perfusion correlates with disease severity in ALS. Neurology 2010;74:821–27
    Abstract/FREE Full TextGoogle Scholar
  41. 41.↵
    1. Miller TM,
    2. Johnston SC
    . Should the Babinski sign be part of the routine neurologic examination? Neurology 2005;65:1165–68
    Abstract/FREE Full TextGoogle Scholar
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 31 (10)
American Journal of Neuroradiology
Vol. 31, Issue 10
1 Nov 2010
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Share
Bookmark this article
MR Spectroscopy Findings in Early Stages of Motor Neuron Disease
M.M. van der Graaff, C. Lavini, E.M. Akkerman, Ch.B. Majoie, A.J. Nederveen, A.H. Zwinderman, F. Brugman, L.H. van den Berg, J.M.B.V. de Jong, M. de Visser
American Journal of Neuroradiology Nov 2010, 31 (10) 1799-1806; DOI: 10.3174/ajnr.A2217
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
Purchase

Jump to section

  • Article
    • Abstract
    • Abbreviations
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study
  • Cerebral degeneration in amyotrophic lateral sclerosis: A prospective multicenter magnetic resonance spectroscopy study
  • Neurochemical correlates of functional decline in amyotrophic lateral sclerosis
  • Corticospinal Motor Neurons and Related Subcerebral Projection Neurons Undergo Early and Specific Neurodegeneration in hSOD1G93A Transgenic ALS Mice
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Kurtosis and Epileptogenic Tubers: A Pilot Study
  • Glutaric Aciduria Type 1: DK vs. Conventional MRI
  • Multiparametric MRI in PEDS Pontine Glioma
Show more Functional

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire
Email this Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
MR Spectroscopy Findings in Early Stages of Motor Neuron Disease
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
M.M. van der Graaff, C. Lavini, E.M. Akkerman, Ch.B. Majoie, A.J. Nederveen, A.H. Zwinderman, F. Brugman, L.H. van den Berg, J.M.B.V. de Jong, M. de Visser
MR Spectroscopy Findings in Early Stages of Motor Neuron Disease
American Journal of Neuroradiology Nov 2010, 31 (10) 1799-1806; DOI: 10.3174/ajnr.A2217

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.